SCHEMBL30664739

SCHEMBL30664739

COC(=O)c1c(N(Cc2ccc(C(C)C)cc2)C(C)=O)sc2c(Cl)c(O)ccc12

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ LMNA P02545 1/20 0.33
▸ THRB P10828 1/20 0.33
▸ RECQL P46063 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ HSP90AA1 P07900 1/20 0.32
▸ GCGR P47871 6/20 0.32
▸ BMP1 P13497 2/20 0.32
▸ TSPO P30536 2/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24683893 1.00 MAPT (0.33) MAPTALDH1A1RAB9ALMNATHRB
SCHEMBL24683860 0.90 HSP90AA1 (0.36) MAPTALDH1A1LMNASMN1; SMN2GAA
SCHEMBL29799884 0.90 HSP90AA1 (0.36) MAPTALDH1A1LMNASMN1; SMN2GAA
SCHEMBL30664654 0.89 HSP90AA1 (0.39) MAPTALDH1A1RAB9ALMNASMN1; SMN2
SCHEMBL24682815 0.89 HSP90AA1 (0.39) MAPTALDH1A1RAB9ALMNASMN1; SMN2
SCHEMBL24683203 0.89 HSP90AA1 (0.39) MAPTALDH1A1RAB9ALMNANPC1
SCHEMBL29799821 0.89 HSP90AA1 (0.39) MAPTALDH1A1RAB9ALMNANPC1
SCHEMBL24683884 0.87 MAPK8 (0.36) MAPTLMNAHSP90AA1BMP1MLYCD
SCHEMBL29799816 0.87 MAPK8 (0.36) MAPTLMNAHSP90AA1BMP1MLYCD
SCHEMBL24683209 0.86 MAPK8 (0.39) ALDH1A1LMNACYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240174629-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY OTCPHARM JSC (RU) 2024-05-30 — — US disclosed
EP-4293017-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY Otcpharm JSC (RU) 2023-12-20 — — EP disclosed
CN-117222630-A 2-acetamido-6-hydroxy-benzothiophene derivatives having antiviral activity OTC制药公司(JSC) 2023-12-12 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240174629-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY ACE2, ACE, EIF2AK2 MAPT 1064/4885ALDH1A1 259/4885RAB9A 3747/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback